BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2790114)

  • 21. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
    Jennison C; Turnbull BW
    Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.
    Emerson SS
    Biometrics; 1995 Sep; 51(3):1152-62. PubMed ID: 7548699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a continuous stopping boundary from an alpha spending function.
    Betensky RA
    Biometrics; 1998 Sep; 54(3):1061-71. PubMed ID: 9750252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL; Gail MH
    Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The reassessment of trial perspectives from interim data--a critical view.
    Bauer P; Koenig F
    Stat Med; 2006 Jan; 25(1):23-36. PubMed ID: 16220517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementing type I & type II error spending for two-sided group sequential designs.
    Rudser KD; Emerson SS
    Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches for optimal sequential decision analysis in clinical trials.
    Carlin BP; Kadane JB; Gelfand AE
    Biometrics; 1998 Sep; 54(3):964-75. PubMed ID: 9750245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new procedure for group sequential analysis in clinical trials.
    Falissard B; Lellouch J
    Biometrics; 1992 Jun; 48(2):373-88. PubMed ID: 1637967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coupled error spending functions for parallel bivariate sequential tests.
    Cook RJ
    Biometrics; 1996 Jun; 52(2):442-50. PubMed ID: 8672698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
    Ayanlowo AO; Redden DT
    Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reviewer's perspective on multiple endpoint issues in clinical trials.
    Huque MF; Sankoh AJ
    J Biopharm Stat; 1997 Nov; 7(4):545-64. PubMed ID: 9358328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating co-primary endpoints collectively in clinical trials.
    Li QH
    Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
    Bénichou J; Lepage E; Chastang C
    Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
    Cheng Y; Shen Y
    Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of experiments with adaptive interim analyses.
    Bauer P; Köhne K
    Biometrics; 1994 Dec; 50(4):1029-41. PubMed ID: 7786985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
    Schäfer H; Müller HH
    Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sequential procedure for monitoring clinical trials against historical controls.
    Xiong X; Tan M; Boyett J
    Stat Med; 2007 Mar; 26(7):1497-511. PubMed ID: 16900551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.